32 results on '"Kuliszewski MA"'
Search Results
2. Comparison of Angiogenic Responses to Pro-Angiogenic Growth Factors in Diabetic Versus Non-Diabetic Microvascular Endothelial Cells
- Author
-
Chen, HH, Liao, C, Alghadeer, SA, Rudenko, D, Kuliszewski, MA, and Leong-Poi, H
- Published
- 2013
- Full Text
- View/download PDF
3. Exploration of S100A6 Effects on the Spatiotemporal Dynamics of Intracellular Calcium in Cardiomyocytes
- Author
-
Mofid, A, Abbasi, C, Kandic, I, Kuliszewski, MA, Matkar, P, Kutryk, MJ, Parker, TG, Gramolini, AO, and Leong-Poi, H
- Published
- 2013
- Full Text
- View/download PDF
4. Comparison of Standard Plasmid DNA Versus Minicircle DNA for Ultrasound-Mediated Gene Delivery
- Author
-
Alghadeer, SA, Rudenko, D, Liao, C, Chen, HH, Kuliszewski, MA, and Leong-Poi, H
- Published
- 2013
- Full Text
- View/download PDF
5. Sustained improvement in perfusion and flow reserve after temporally separated delivery of vascular endothelial growth factor and angiopoietin-1 plasmid deoxyribonucleic Acid.
- Author
-
Smith AH, Kuliszewski MA, Liao C, Rudenko D, Stewart DJ, and Leong-Poi H
- Published
- 2012
6. Comparison of gene delivery techniques for therapeutic angiogenesis ultrasound-mediated destruction of carrier microbubbles versus direct intramuscular injection.
- Author
-
Kobulnik J, Kuliszewski MA, Stewart DJ, Lindner JR, Leong-Poi H, Kobulnik, Jeremy, Kuliszewski, Michael A, Stewart, Duncan J, Lindner, Jonathan R, and Leong-Poi, Howard
- Abstract
Objectives: This study was designed to compare the efficacy of angiogenic gene delivery by ultrasound-mediated (UM) destruction of intravenous carrier microbubbles to direct intramuscular (IM) injections.Background: Current trials of gene therapy for angiogenesis remain limited by suboptimal, invasive delivery techniques.Methods: Hind-limb ischemia was produced by iliac artery ligation in 99 rats. In 32 rats, UM delivery of green fluorescent protein (GFP)/vascular endothelial growth factor-165 (VEGF(165)) plasmid deoxyribonucleic acid was performed. Thirty-five animals received IM injections of VEGF(165)/GFP plasmid. Remaining rats received no treatment. Before delivery (day 14 after ligation) and at days 17, 21, and 28 and week 8 after ligation, microvascular blood volume and microvascular blood flow to the proximal hind limbs were assessed by contrast-enhanced ultrasound (n = 8 per group). Total transfection was assessed by reverse transcriptase-polymerase chain reaction, and localization of transfection was determined by immunohistochemistry.Results: By day 28, both IM and UM delivery of VEGF(165) produced significant increases in microvascular blood volume and microvascular blood flow. Whereas increases in microvascular blood volume were similar between treatment groups, microvascular blood flow was greater (p < 0.005) in UM-treated animals as compared with IM-treated animals, persisting to week 8. The VEGF(165)/GFP messenger ribonucleic acid expression was greater (p < 0.05) for IM-treated animals. A strong GFP signal was detected for both groups and was localized to focal perivascular regions and myocytes around injection sites for IM and to the vascular endothelium of arterioles/capillaries in a wider distribution for UM delivery.Conclusions: Despite lower transfection levels, UM delivery of VEGF(165) is as effective as IM injections. The UM delivery results in directed vascular transfection over a wider distribution, which may account for the more efficient angiogenesis. [ABSTRACT FROM AUTHOR]- Published
- 2009
- Full Text
- View/download PDF
7. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.
- Author
-
Verma S, Kuliszewski MA, Li S, Szmitko PE, Zucco L, Wang C, Badiwala MV, Mickle DAG, Weisel RD, Fedak PWM, Stewart DJ, and Kutryk MJB
- Published
- 2004
8. Cardiac Overexpression of S100A6 Attenuates Cardiomyocyte Apoptosis and Reduces Infarct Size After Myocardial Ischemia-Reperfusion.
- Author
-
Mofid A, Newman NS, Lee PJ, Abbasi C, Matkar PN, Rudenko D, Kuliszewski MA, Chen HH, Afrasiabi K, Tsoporis JN, Gramolini AO, Connelly KA, Parker TG, and Leong-Poi H
- Subjects
- Animals, Animals, Newborn, Blotting, Western, Cell Cycle Proteins biosynthesis, Disease Models, Animal, Immunohistochemistry, In Situ Nick-End Labeling, Myocardial Infarction etiology, Myocardial Infarction metabolism, Myocardial Reperfusion Injury metabolism, Myocytes, Cardiac pathology, Rats, Rats, Inbred F344, Real-Time Polymerase Chain Reaction, S100 Calcium Binding Protein A6 biosynthesis, Signal Transduction, Apoptosis, Cell Cycle Proteins genetics, Gene Expression Regulation, Developmental, Myocardial Infarction genetics, Myocardial Reperfusion Injury complications, Myocytes, Cardiac metabolism, RNA genetics, S100 Calcium Binding Protein A6 genetics
- Abstract
Background: Cardiomyocyte-specific transgenic mice overexpressing S100A6, a member of the family of EF-hand calcium-binding proteins, develop less cardiac hypertrophy, interstitial fibrosis, and myocyte apoptosis after permanent coronary ligation, findings that support S100A6 as a potential therapeutic target after acute myocardial infarction. Our purpose was to investigate S100A6 gene therapy for acute myocardial ischemia-reperfusion., Methods and Results: We first performed in vitro studies to examine the effects of S100A6 overexpression and knockdown in rat neonatal cardiomyocytes. S100A6 overexpression improved calcium transients and protected against apoptosis induced by hypoxia-reoxygenation via enhanced calcineurin activity, whereas knockdown of S100A6 had detrimental effects. For in vivo studies, human S100A6 plasmid or empty plasmid was delivered to the left ventricular myocardium by ultrasound-targeted microbubble destruction in Fischer-344 rats 2 days prior to a 30-minute ligation of the left anterior descending coronary artery followed by reperfusion. Control animals received no therapy. Pretreatment with S100A6 gene therapy yielded a survival advantage compared to empty-plasmid and nontreated controls. S100A6-pretreated animals had reduced infarct size and improved left ventricular systolic function, with less myocyte apoptosis, attenuated cardiac hypertrophy, and less cardiac fibrosis., Conclusions: S100A6 overexpression by ultrasound-targeted microbubble destruction helps ameliorate myocardial ischemia-reperfusion, resulting in lower mortality and improved left ventricular systolic function post-ischemia-reperfusion via attenuation of apoptosis, reduction in cardiac hypertrophy, and reduced infarct size. Our results indicate that S100A6 is a potential therapeutic target for acute myocardial infarction., (© 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell.)
- Published
- 2017
- Full Text
- View/download PDF
9. Novel regulatory role of neuropilin-1 in endothelial-to-mesenchymal transition and fibrosis in pancreatic ductal adenocarcinoma.
- Author
-
Matkar PN, Singh KK, Rudenko D, Kim YJ, Kuliszewski MA, Prud'homme GJ, Hedley DW, and Leong-Poi H
- Subjects
- Animals, Carcinoma, Pancreatic Ductal metabolism, Carcinoma, Pancreatic Ductal therapy, Cell Line, Tumor, Cells, Cultured, Chemoradiotherapy, Drug Therapy, Female, Fibrosis genetics, Fibrosis metabolism, Humans, Male, Neuropilin-1 metabolism, Pancreatic Neoplasms metabolism, Pancreatic Neoplasms therapy, RNA Interference, Rats, Nude, Xenograft Model Antitumor Assays, Carcinoma, Pancreatic Ductal genetics, Epithelial-Mesenchymal Transition genetics, Neuropilin-1 genetics, Pancreatic Neoplasms genetics
- Abstract
Pancreatic ductal adenocarcinoma (PDAC) is characterized by an intense fibrotic reaction termed tumor desmoplasia, which is in part responsible for its aggressiveness. Endothelial cells have been shown to display cellular plasticity in the form of endothelial-to-mesenchymal transition (EndMT) that serves as an important source of fibroblasts in pathological disorders, including cancer. Angiogenic co-receptor, neuropilin-1 (NRP- 1) actively binds TGFβ1, the primary mediator of EndMT and is involved in oncogenic processes like epithelial-to-mesenchymal transition (EMT). NRP-1 and TGFβ1 signaling have been shown to be aberrantly up-regulated in PDAC. We report herein a positive correlation between NRP-1 levels, EndMT and fibrosis in human PDAC xenografts. Loss of NRP-1 in HUVECs limited TGFβ1-induced EndMT as demonstrated by gain of endothelial and loss of mesenchymal markers, while maintaining endothelial cell architecture. Knockdown of NRP-1 down-regulated TGFβ canonical signaling (pSMAD2) and associated pro-fibrotic genes. Overexpression of NRP-1 exacerbated TGFβ1-induced EndMT and up-regulated TGFβ signaling and expression of pro-fibrotic genes. In vivo, loss of NRP-1 attenuated tumor perfusion and size, accompanied by reduction in EndMT and fibrosis. This study defines a previously unrecognized role of NRP-1 in regulating TGFβ1-induced EndMT and fibrosis, and advocates NRP-1 as a therapeutic target to reduce tumor fibrosis and PDAC progression.
- Published
- 2016
- Full Text
- View/download PDF
10. Prospect of ultrasound-mediated gene delivery in cardiovascular applications.
- Author
-
Chen HH, Matkar PN, Afrasiabi K, Kuliszewski MA, and Leong-Poi H
- Subjects
- Animals, Genetic Therapy trends, Humans, Microbubbles, Transfection, Ultrasonic Therapy trends, Cardiovascular Diseases genetics, Cardiovascular Diseases therapy, Gene Transfer Techniques trends, Genetic Therapy methods, Ultrasonic Therapy methods
- Abstract
Introduction: The field of regenerative medicine has evolved over the years, investigating gene and stem/progenitor cell therapies to help address the increasing burden of cardiovascular disease (CVD). While the lack of success of gene therapy in clinical trials has dampened enthusiasm, the search continues for a successful and translatable gene therapy strategy for CVD. Ultrasound-mediated gene delivery (UMGD) is a non-invasive technique for gene delivery that utilizes gene-bearing carrier microbubbles and high power ultrasound to facilitate transfection in vivo. Many pre-clinical studies have shown benefit in animal models of CVD, but this has yet to be translated to human applications., Areas Covered: In this review, the basic principles of UMGD will be examined along with an overview of pre-clinical studies to date in CVD, focusing on cardiac and vascular applications and key findings. In addition, the potential path to the clinical translation of UMGD is discussed., Expert Opinion: Ultrasound-mediated gene delivery holds promise as a non-invasive technique for gene delivery in CVD, with the ability to deliver multiple genes with repeated deliveries over time. If the substantial hurdles to clinical translation can be overcome, UMGD may prove to be a key aspect in the success of cardiovascular gene therapy in the future.
- Published
- 2016
- Full Text
- View/download PDF
11. Therapeutic Angiogenesis by Ultrasound-Mediated MicroRNA-126-3p Delivery.
- Author
-
Cao WJ, Rosenblat JD, Roth NC, Kuliszewski MA, Matkar PN, Rudenko D, Liao C, Lee PJ, and Leong-Poi H
- Subjects
- Angiogenic Proteins genetics, Angiogenic Proteins metabolism, Animals, Cells, Cultured, Disease Models, Animal, Gene Expression Regulation, Hindlimb, Humans, Ischemia genetics, Ischemia metabolism, Ischemia physiopathology, Male, MicroRNAs genetics, Microbubbles, Microcirculation, Rats, Inbred F344, Regional Blood Flow, Time Factors, Genetic Therapy methods, Human Umbilical Vein Endothelial Cells metabolism, Ischemia therapy, MicroRNAs metabolism, Microvessels physiopathology, Muscle, Skeletal blood supply, Neovascularization, Physiologic, Transfection methods, Ultrasonics
- Abstract
Objective: MicroRNAs are involved in many critical functions, including angiogenesis. Ultrasound-targeted microbubble destruction (UTMD) is a noninvasive technique for targeted vascular transfection of plasmid DNA and may be well suited for proangiogenic microRNA delivery. We aimed to investigate UTMD of miR-126-3p for therapeutic angiogenesis in chronic ischemia., Approach and Results: The angiogenic potential of miR-126-3p was tested in human umbilical vein endothelial cells in vitro. UTMD of miR-126-3p was tested in vivo in Fischer-344 rats before and after chronic left femoral artery ligation, evaluating target knockdown, miR-126-3p and miR-126-5p expression, phosphorylated Tie2 levels, microvascular perfusion, and vessel density. In vitro, miR-126-3p-transfected human umbilical vein endothelial cells showed repression of sprouty-related protein-1 and phosphatidylinositol-3-kinase regulatory subunit 2, negative regulators of vascular endothelial growth factor and angiopoietin-1 signaling, increased phosphorylated Tie2 mediated by knockdown of phosphatidylinositol-3-kinase regulatory subunit 2 and greater angiogenic potential mediated by both vascular endothelial growth factor/vascular endothelial growth factor R2 and angiopoietin-1 /Tie2 effects. UTMD of miR-126-3p resulted in targeted vascular transfection, peaking early after delivery and lasting for >3 days, and resulting in inhibition of sprouty-related protein-1 and phosphatidylinositol-3-kinase regulatory subunit 2, with minimal uptake in remote organs. Finally, UTMD of miR-126-3p to chronic ischemic hindlimb muscle resulted in improved perfusion, vessel density, enhanced arteriolar formation, pericyte coverage, and phosphorylated Tie2 levels, without affecting miR-126-5p or delta-like 1 homolog levels., Conclusions: UTMD of miR-126 results in improved tissue perfusion and vascular density in the setting of chronic ischemia by repressing sprouty-related protein-1 and phosphatidylinositol-3-kinase regulatory subunit 2 and enhancing vascular endothelial growth factor and angiopoietin-1 signaling, with no effect on miR-126-5p. UTMD is a promising platform for microRNA delivery, with applications for therapeutic angiogenesis., (© 2015 American Heart Association, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
12. A modified portfolio diet complements medical management to reduce cardiovascular risk factors in diabetic patients with coronary artery disease.
- Author
-
Keith M, Kuliszewski MA, Liao C, Peeva V, Ahmed M, Tran S, Sorokin K, Jenkins DJ, Errett L, and Leong-Poi H
- Subjects
- Aged, Biomarkers blood, Blood Glucose metabolism, Case-Control Studies, Cholesterol, HDL blood, Cholesterol, LDL blood, Coronary Artery Disease complications, Diabetes Mellitus, Type 2 complications, Diet, Fat-Restricted, Dietary Fats administration & dosage, Dietary Fiber administration & dosage, Energy Intake, Female, Homocysteine blood, Humans, Male, Middle Aged, Motor Activity, Patient Compliance, Pilot Projects, Risk Factors, Soybean Proteins administration & dosage, Coronary Artery Disease diet therapy, Diabetes Mellitus, Type 2 diet therapy
- Abstract
Background & Aims: Secondary prevention can improve outcomes in high risk patients. This study investigated the magnitude of cardiovascular risk reduction associated with consumption of a modified portfolio diet in parallel with medical management., Design: 30 patients with type II diabetes, 6 weeks post bypass surgery received dietary counseling on a Modified Portfolio Diet (MPD) (low fat, 8 g/1000 kcal viscous fibres, 17 g/1000 kcal soy protein and 22 g/1000 kcal almonds). Lipid profiles, endothelial function and markers of glycemic control, oxidative stress and inflammation were measured at baseline and following two and four weeks of intervention. Seven patients with no diet therapy served as time controls., Results: Consumption of the MPD resulted in a 19% relative reduction in LDL (1.9 ± 0.8 vs 1.6 ± 0.6 mmol/L, p < 0.001) with no change in HDL cholesterol. Homocysteine levels dropped significantly (10.1 ± 2.7 vs 7.9 ± 4 μmol/L, p = 0.006) over the study period. Flow mediated dilatation increased significantly in treated patients (3.8 ± 3.8% to 6.5 ± 3.6%, p = 0.004) while remaining constant in controls (p = 0.6). Endothelial progenitor cells numbers (CD34+, CD 133+ and UEA-1+) increased significantly following MPD consumption (p < 0.02) with no difference in migratory capacity. In contrast, time controls showed no significant changes., Conclusion: Dietary intervention in medically managed, high risk patients resulted in important reductions in risk factors. Clinical Trials registry number NCT00462436., (Copyright © 2014 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
13. Perlecan heparan sulfate proteoglycan is a critical determinant of angiogenesis in response to mouse hind-limb ischemia.
- Author
-
Qiang B, Lim SY, Lekas M, Kuliszewski MA, Wolff R, Osherov AB, Rudenko D, Leong-Poi H, Noyan H, Husain M, Tran K, Tryggvason K, Hedin U, Tran-Lundmark K, and Strauss BH
- Subjects
- Animals, Blotting, Western, Cell Proliferation, Disease Models, Animal, Fibroblast Growth Factor 2 metabolism, Gene Expression Regulation physiology, Immunohistochemistry, Ischemia complications, Ischemia pathology, Laser-Doppler Flowmetry, Mice, Mice, Inbred C57BL, Neovascularization, Pathologic etiology, Neovascularization, Pathologic genetics, RNA, Messenger genetics, Real-Time Polymerase Chain Reaction, Vascular Endothelial Growth Factor A genetics, Heparan Sulfate Proteoglycans physiology, Hindlimb blood supply, Ischemia metabolism, Neovascularization, Pathologic metabolism
- Abstract
Background: Perlecan is a heparan sulfate proteoglycan (HSPG) constituent of the extracellular matrix with roles in cell growth, differentiation, and angiogenesis. The role of the HS side chains in regulating in vivo angiogenesis after hind-limb ischemia is unknown., Methods: Heparan sulfate (HS)-deficient perlecan (Hspg2(Δ3/Δ3)) mice (n = 35), containing normal perlecan core protein but deficient in HS side chains, and wild-type (n = 33) littermates underwent surgical induction of hind-limb ischemia. Laser Doppler perfusion imaging (LDPI) and contrast-enhanced ultrasonography (CEU) provided serial assessment of hind-limb perfusion. Harvested muscles underwent immunostaining for endothelial cell density (CD31), real-time reverse transcription polymerase chain reaction RT-PCR for vascular endothelial growth factor (VEGF) mRNA expression and western blot analysis for VEGF and fibroblast growth factor (FGF)2 protein expression at days 2 and 28., Results: Serial LDPI showed significantly greater perfusion recovery in ischemic limbs of wild-type compared with Hspg2(Δ3/Δ3) mice. CEU showed that normalized microvascular perfusion was increased in wild-type compared with Hspg2(Δ3/Δ3) mice at day 28 (0.67 ± 0.12 vs 0.26 ± 0.08; P = 0.001). CD31-positive cell counts were significantly higher in wild-type compared with Hspg2(Δ3/Δ3) mice on day 28 (122 ± 30 cells vs 84 ± 34 cells per high-power field [HPF]; P < 0.05). Endogenous VEGF mRNA expression (P < 0.05) and VEGF protein expression (P < 0.002) were significantly decreased in the ischemic limbs of Hspg2(Δ3/Δ3) mice compared with wild-type mice at day 2 and day 28, respectively. FGF2 protein expression showed no significant differences., Conclusions: These results suggest that the HS side chains in perlecan are important mediators of the angiogenic response to ischemia through a mechanism that involves upregulation of VEGF expression., (Copyright © 2014 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
14. Survivin gene therapy attenuates left ventricular systolic dysfunction in doxorubicin cardiomyopathy by reducing apoptosis and fibrosis.
- Author
-
Lee PJ, Rudenko D, Kuliszewski MA, Liao C, Kabir MG, Connelly KA, and Leong-Poi H
- Subjects
- Animals, Apoptosis physiology, Cardiomyopathies drug therapy, Cardiomyopathies genetics, Cell Line, Genetic Therapy methods, Inhibitor of Apoptosis Proteins genetics, Mice, Microtubule-Associated Proteins genetics, Myocardium metabolism, Rats, Repressor Proteins genetics, Survivin, Ventricular Dysfunction, Left chemically induced, Ventricular Dysfunction, Left genetics, Ventricular Dysfunction, Left metabolism, Apoptosis drug effects, Doxorubicin toxicity, Fibrosis metabolism, Inhibitor of Apoptosis Proteins metabolism, Microtubule-Associated Proteins metabolism, Repressor Proteins metabolism, Ventricular Dysfunction, Left therapy
- Abstract
Aims: The aim of this study was to investigate anti-apoptotic gene therapy using ultrasound-mediated plasmid delivery of survivin, an inhibitor of apoptosis protein, to prevent apoptosis and to attenuate left ventricular (LV) systolic dysfunction in a model of heart failure induced by doxorubicin., Methods and Results: Effect of survivin transduction was investigated in vitro in rat cardiomyoblasts. After survivin transduction, survivin protein was detected in cell culture supernate confirming secretion of extracellular survivin. Under doxorubicin stimulation, survivin-transduced cells had significantly reduced apoptosis; however, incubation with survivin-conditioned media also showed reduced apoptosis that was absent with null-conditioned media. Doxorubicin-induced cardiomyopathy was established in Fischer rats. Subsets of animals underwent ultrasound-mediated survivin gene delivery or empty vector gene delivery at Week 3. Control rats received doxorubicin alone. Animals were studied using PCR, immunohistochemistry, echocardiography, and invasive haemodynamic studies out to Week 6. By Week 6, LV % fractional shortening by echocardiography and systolic function by pressure-volume loops were greater in survivin treated when compared with control- and empty-treated animals. There was reduced apoptosis by TUNEL and caspase activity in survivin-treated animals compared with control and empty treated at Week 4, with reduced interstitial fibrosis at Week 6., Conclusion: Survivin gene therapy can attenuate the progression of LV systolic dysfunction in doxorubicin cardiomyopathy. This effect can be attributed to decreased myocyte apoptosis and prevention of maladaptive LV remodelling, by both direct myocyte transfection and potentially by paracrine mechanisms.
- Published
- 2014
- Full Text
- View/download PDF
15. Circulating angiogenic cell dysfunction in patients with hereditary hemorrhagic telangiectasia.
- Author
-
Zucco L, Zhang Q, Kuliszewski MA, Kandic I, Faughnan ME, Stewart DJ, and Kutryk MJ
- Subjects
- AC133 Antigen, Activin Receptors, Type II, Adult, Annexin A5, Antigens, CD metabolism, Antigens, CD34 metabolism, Apoptosis physiology, Blood Vessels physiology, Endoglin, Female, Flow Cytometry, Glycoproteins metabolism, Humans, Male, Microscopy, Fluorescence, Nitric Oxide Synthase Type III, Peptides metabolism, Real-Time Polymerase Chain Reaction, Receptors, Cell Surface, Receptors, Vascular Endothelial Growth Factor metabolism, Reverse Transcriptase Polymerase Chain Reaction, Telangiectasia, Hereditary Hemorrhagic metabolism, Young Adult, Blood Vessels pathology, Leukocytes, Mononuclear metabolism, Regeneration physiology, Telangiectasia, Hereditary Hemorrhagic pathology
- Abstract
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant vascular disorder. Circulating angiogenic cells (CACs) play an important role in vascular repair and regeneration. This study was designed to examine the function of CACs derived from patients with HHT. Peripheral blood mononuclear cells (PBMNCs) isolated from patients with HHT and age- and gender-matched healthy volunteers were assessed for expression of CD34, CD133 and VEGF receptor 2 by flow cytometry. PBMNCs were cultured to procure early outgrowth CACs. Development of endothelial cell (EC) phenotype in CACs was analyzed by fluorescence microscopy. CAC apoptosis was assayed with Annexin V staining, and CAC migration assessed by a modified Boyden chamber assay. mRNA expression of endoglin (ENG), activin receptor-like kinase-1 (ACVLR1 or ALK1) and endothelial nitric oxide synthase (eNOS) in CACs was measured by real time RT-PCR. The percentage of CD34+ cells in PBMNCs from HHT patients was significantly higher than in PBMNCs of healthy controls. CACs derived from patients with HHT not only showed a significant reduction in EC-selective surface markers following 7-day culture, but also a significant increase in the rate of basal apoptosis and blunted migration in response to vascular endothelial growth factor and stromal cell-derived factor-1. CACs from HHT patients expressed significantly lower levels of ENG, ALK1 and eNOS mRNAs. In conclusion, CACs from patients with HHT exhibited various functional impairments, suggesting a reduced regenerative capacity of CACs to repair the vascular lesions seen in HHT patients.
- Published
- 2014
- Full Text
- View/download PDF
16. Optimization of Ultrasound-mediated Anti-angiogenic Cancer Gene Therapy.
- Author
-
Fujii H, Matkar P, Liao C, Rudenko D, Lee PJ, Kuliszewski MA, Prud'homme GJ, and Leong-Poi H
- Abstract
Ultrasound-targeted microbubble destruction (UTMD) can be used to deliver silencing gene therapy to tumors. We hypothesized that UTMD would be effective in suppressing angiogenesis within tumors, and that modulation of the ultrasound pulsing intervals (PI) during UTMD would affect the magnitude of target knockdown. We performed UTMD of vascular endothelial growth factor receptor-2 (VEGFR2) short hairpin (sh)RNA plasmid in an heterotopic mammary adenocarcinoma model in rats, evaluating PIs of 2, 5, 10, and 20 seconds. We demonstrated that UTMD with a PI of 10 seconds resulted in the greatest knockdown of VEGFR2 by PCR, immunostaining, western blotting, smaller tumor volumes and perfused areas, and lower tumor microvascular blood volume (MBV) and flow by contrast-enhanced ultrasound (CEU) compared with UTMD-treated tumors at 2, 5, and 20 seconds, control tumors, tumors treated with intravenous shRNA plasmid and scrambled plasmid. CEU perfusion assessment using the therapeutic probe demonstrated that tumors were fully replenished with microbubbles within 10 seconds, but incompletely replenished at PI-2 and PI-5 seconds. In conclusion, for anti-VEGFR2 cancer gene therapy by UTMD, PI of 10 seconds results in higher target knockdown and a greater anti-angiogenic effect. Complete replenishment of tumor vasculature with silencing gene-bearing microbubbles in between destructive pulses of UTMD is required to maximize the efficacy of anti-angiogenic cancer gene therapy.Molecular Therapy - Nucleic Acids (2013) 2, e94; doi:10.1038/mtna.2013.20; published online 21 May 2013.
- Published
- 2013
- Full Text
- View/download PDF
17. A direct comparison of endothelial progenitor cell dysfunction in rat metabolic syndrome and diabetes.
- Author
-
Kuliszewski MA, Ward MR, Kowalewski JW, Smith AH, Stewart DJ, Kutryk MJ, and Leong-Poi H
- Subjects
- Animals, Cells, Cultured, Male, Rats, Rats, Zucker, Diabetes Mellitus, Experimental physiopathology, Endothelium, Vascular cytology, Metabolic Syndrome physiopathology, Neovascularization, Physiologic, Stem Cells physiology
- Abstract
Objectives: Diabetes mellitus (DM) is associated with impairment of endothelial progenitor cells (EPCs), but the effects of metabolic syndrome (MS) on EPCs have been less well characterized. We hypothesized that in the presence of MS, the number and functionality of EPCs would be markedly reduced, and would be similar to DM., Methods: Mononuclear cells were isolated from the bone-marrow (BM) and peripheral blood of lean Zucker, obese Zucker, a model of MS, and Zucker diabetic fatty rats. Cultured BM-EPCs underwent in vitro functional testing and the ability of BM-EPCs to promote neovascularization in vivo was assessed in a model of hindlimb ischemia in athymic mice., Results: While circulating EPC numbers were similarly reduced in both MS and DM rats, BM-derived EPC numbers were less affected. In vitro testing of cultured BM-EPCs from obese Zucker demonstrated a marked reduction in EPC differentiation, a greater propensity to apoptosis, a reduced migratory response and matrigel tubule formation, similar to findings in Zucker diabetic fatty rats. When delivered to the ischemic hindlimb of athymic mice, the recovery of perfusion using both BM-EPCs from obese Zucker and Zucker diabetic fatty rats were diminished, as compared to lean Zuckers., Conclusion: In the presence of the MS, BM-derived EPCs develop marked functional impairment, resulting in severely reduced angiogenic capacity in vivo. Similar to DM, EPC dysfunction may play a prominent role in the pathogenesis of vascular complications in the MS, and may potentially limit the use of BM-derived EPCs for therapeutic angiogenesis., (Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2013
- Full Text
- View/download PDF
18. Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles.
- Author
-
Xie A, Belcik T, Qi Y, Morgan TK, Champaneri SA, Taylor S, Davidson BP, Zhao Y, Klibanov AL, Kuliszewski MA, Leong-Poi H, Ammi A, and Lindner JR
- Subjects
- Animals, Contrast Media, Disease Models, Animal, Mice, Mice, Inbred C57BL, Reproducibility of Results, Ultrasonography, Endothelium, Vascular diagnostic imaging, Endothelium, Vascular metabolism, Genetic Therapy methods, Microbubbles, Transfection methods, Ultrasonics
- Abstract
Objectives: Ultrasound-mediated gene delivery can be amplified by acoustic disruption of microbubble carriers that undergo cavitation. We hypothesized that endothelial targeting of microbubbles bearing cDNA is feasible and, through optimizing proximity to the vessel wall, increases the efficacy of gene transfection., Background: Contrast ultrasound-mediated gene delivery is a promising approach for site-specific gene therapy, although there are concerns with the reproducibility of this technique and the safety when using high-power ultrasound., Methods: Cationic lipid-shelled decafluorobutane microbubbles bearing a targeting moiety were prepared and compared with nontargeted microbubbles. Microbubble targeting efficiency to endothelial adhesion molecules (P-selectin or intercellular adhesion molecule [ICAM]-1) was tested using in vitro flow chamber studies, intravital microscopy of tumor necrosis factor-alpha (TNF-α)-stimulated murine cremaster muscle, and targeted contrast ultrasound imaging of P-selectin in a model of murine limb ischemia. Ultrasound-mediated transfection of luciferase reporter plasmid charge coupled to microbubbles in the post-ischemic hindlimb muscle was assessed by in vivo optical imaging., Results: Charge coupling of cDNA to the microbubble surface was not influenced by the presence of targeting ligand, and did not alter the cavitation properties of cationic microbubbles. In flow chamber studies, surface conjugation of cDNA did not affect attachment of targeted microbubbles at microvascular shear stresses (0.6 and 1.5 dyne/cm(2)). Attachment in vivo was also not affected by cDNA according to intravital microscopy observations of venular adhesion of ICAM-1-targeted microbubbles and by ultrasound molecular imaging of P-selectin-targeted microbubbles in the post-ischemic hindlimb in mice. Transfection at the site of high acoustic pressures (1.0 and 1.8 MPa) was similar for control and P-selectin-targeted microbubbles but was associated with vascular rupture and hemorrhage. At 0.6 MPa, there were no adverse bioeffects, and transfection was 5-fold greater with P-selectin-targeted microbubbles., Conclusions: We conclude that ultrasound-mediated transfection at safe acoustic pressures can be markedly augmented by endothelial juxtaposition., (Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.)
- Published
- 2012
- Full Text
- View/download PDF
19. Contrast ultrasound and targeted microbubbles: diagnostic and therapeutic applications for angiogenesis.
- Author
-
Smith AH, Fujii H, Kuliszewski MA, and Leong-Poi H
- Subjects
- Animals, Cardiovascular Diseases genetics, Cardiovascular Diseases physiopathology, Cardiovascular Diseases therapy, Gene Transfer Techniques, Genetic Therapy, Humans, Predictive Value of Tests, Translational Research, Biomedical, Cardiovascular Diseases diagnostic imaging, Contrast Media, Microbubbles, Molecular Imaging methods, Neovascularization, Physiologic genetics, Ultrasonography, Interventional
- Abstract
Angiogenesis represents the formation of new capillaries from existing vasculature, and as such plays a critical role in the response to ischemia in the setting of chronic coronary artery and peripheral vascular disease. Recent technological advances in non-invasive imaging modalities now allow the molecular imaging of angiogenesis. One such technique is contrast-enhanced ultrasound using microbubbles targeted against molecular markers of the angiogenic process. The ability to non-invasively image the angiogenic process would be useful in risk stratifying patients with arterial occlusive disease and would aid in the evaluation of new therapies to promote angiogenesis in ischemic cardiac and skeletal muscle. Furthermore, ultrasound technologies have also been developed that allow targeted angiogenic gene therapy using high-power ultrasound and DNA-bearing microbubbles. This review will focus specifically on recent advances in (1) contrast-enhanced ultrasound molecular imaging techniques for the evaluation of angiogenesis and (2) ultrasound-mediated gene delivery for therapeutic angiogenesis, techniques that have potential for translation to clinical practice.
- Published
- 2011
- Full Text
- View/download PDF
20. Nocturnal hemodialysis is associated with restoration of early-outgrowth endothelial progenitor-like cell function.
- Author
-
Yuen DA, Kuliszewski MA, Liao C, Rudenko D, Leong-Poi H, and Chan CT
- Subjects
- Adult, Analysis of Variance, Angiopoietin-1 metabolism, Animals, Blood Flow Velocity, Capillaries physiopathology, Case-Control Studies, Cells, Cultured, Disease Models, Animal, Endothelial Cells metabolism, Endothelial Cells transplantation, Hindlimb, Humans, Ischemia diagnostic imaging, Ischemia metabolism, Ischemia pathology, Ischemia surgery, Kidney Failure, Chronic metabolism, Kidney Failure, Chronic pathology, Male, Middle Aged, Ontario, Phenotype, Rats, Rats, Nude, Regional Blood Flow, Stem Cell Transplantation, Stem Cells metabolism, Time Factors, Ultrasonography, Endothelial Cells pathology, Hemodialysis, Home methods, Ischemia physiopathology, Kidney Failure, Chronic therapy, Muscle, Skeletal blood supply, Neovascularization, Physiologic, Stem Cells pathology
- Abstract
Background and Objectives: Angiogenesis is a key response to tissue ischemia that may be impaired by uremia. Although early-outgrowth endothelial progenitor-like cells promote angiogenesis in the setting of normal renal function, cells from uremic patients are dysfunctional. When compared with conventional hemodialysis, it was hypothesized that nocturnal hemodialysis would improve the in vivo angiogenic activity of these cells in a well described model of ischemic vascular disease., Design, Setting, Participants, and Measurements: Early-outgrowth endothelial progenitor-like cells were cultured from healthy controls (n = 5) and age- and gender-matched conventional hemodialysis (12 h/wk, n = 10) and nocturnal hemodialysis (30 to 50 h/wk, n = 9) patients. Cells (5 × 10(5)) or saline were injected into the ischemic hindlimb of athymic nude rats 1 day after left common iliac artery ligation., Results: Although conventional dialysis cell injection had no effect versus saline, nocturnal hemodialysis and healthy control cell injection significantly improved ischemic hindlimb perfusion and capillary density. Nocturnal hemodialysis cell injection was also associated with significant increases in endogenous angiopoietin 1 expression in the ischemic hindlimb compared with saline and conventional dialysis cell injection., Conclusions: In contrast to a conventional dialytic regimen, nocturnal hemodialysis is associated with a significantly improved ability of early-outgrowth endothelial progenitor-like cells to promote angiogenesis and thus restore perfusion in a model of ischemic vascular disease.
- Published
- 2011
- Full Text
- View/download PDF
21. Vascular gene transfer of SDF-1 promotes endothelial progenitor cell engraftment and enhances angiogenesis in ischemic muscle.
- Author
-
Kuliszewski MA, Kobulnik J, Lindner JR, Stewart DJ, and Leong-Poi H
- Subjects
- Animals, Cell Movement genetics, Cells, Cultured, Chemokine CXCL12 genetics, Endothelium, Vascular physiopathology, Genetic Therapy, Hindlimb blood supply, Ischemia genetics, Ischemia metabolism, Ischemia physiopathology, Rats, Rats, Inbred F344, Transfection, Transplants, Chemokine CXCL12 metabolism, Endothelial Cells metabolism, Ischemia therapy, Muscle, Skeletal blood supply, Neovascularization, Physiologic, Stem Cells metabolism
- Abstract
Gene therapy approaches to enhance endothelial progenitor cell (EPC) homing may augment cell engraftment to ischemic tissue and lead to a greater therapeutic response. Therefore, we assessed the effects of ultrasound-mediated (UM) transfection of the chemokine stromal cell-derived factor-1 (SDF-1) on homing and engraftment of intravenously administered EPCs and the subsequent angiogenic response in chronically ischemic skeletal muscle. Bone marrow-derived EPCs were isolated from donor Fisher 344 rats, cultured and labeled in preparation for injection into recipient animals via a jugular vein. Using a model of chronic hindlimb ischemia in rats, we demonstrated that UM destruction of intravenous carrier microbubbles loaded with SDF-1 plasmid DNA resulted in targeted transfection of the vascular endothelium within ischemic muscle and greater local engraftment of EPCs. The combination of SDF-1gene therapy and EPCs lead to the greatest increase in tissue perfusion and microvascular density within ischemic muscle, compared to no treatment or either monotherapy alone. Our results demonstrate that UM transfection of SDF-1 improves EPC targeting to chronically ischemic tissue, enhancing vascular engraftment and leading to a more robust neovascularization response.
- Published
- 2011
- Full Text
- View/download PDF
22. Fluorescent microangiography is a novel and widely applicable technique for delineating the renal microvasculature.
- Author
-
Advani A, Connelly KA, Yuen DA, Zhang Y, Advani SL, Trogadis J, Kabir MG, Shachar E, Kuliszewski MA, Leong-Poi H, Stewart DJ, and Gilbert RE
- Subjects
- Animals, Kidney pathology, Kidney surgery, Male, Nephrectomy, Radiography, Rats, Rats, Sprague-Dawley, Fluorescein Angiography methods, Kidney blood supply, Kidney diagnostic imaging, Microvessels diagnostic imaging
- Abstract
Rarefaction of the renal microvasculature correlates with declining kidney function. However, current technologies commonly used for its evaluation are limited by their reliance on endothelial cell antigen expression and assessment in two dimensions. We set out to establish a widely applicable and unbiased optical sectioning method to enable three dimensional imaging and reconstruction of the renal microvessels based on their luminal filling. The kidneys of subtotally nephrectomized (SNx) rats and their sham-operated counterparts were subjected to either routine two-dimensional immunohistochemistry or the novel technique of fluorescent microangiography (FMA). The latter was achieved by perfusion of the kidney with an agarose suspension of fluorescent polystyrene microspheres followed by optical sectioning of 200 µm thick cross-sections using a confocal microscope. The fluorescent microangiography method enabled the three-dimensional reconstruction of virtual microvascular casts and confirmed a reduction in both glomerular and peritubular capillary density in the kidneys of SNx rats, despite an overall increase in glomerular volume. FMA is an uncomplicated technique for evaluating the renal microvasculature that circumvents many of the limitations imposed by conventional analysis of two-dimensional tissue sections.
- Published
- 2011
- Full Text
- View/download PDF
23. Culture-modified bone marrow cells attenuate cardiac and renal injury in a chronic kidney disease rat model via a novel antifibrotic mechanism.
- Author
-
Yuen DA, Connelly KA, Advani A, Liao C, Kuliszewski MA, Trogadis J, Thai K, Advani SL, Zhang Y, Kelly DJ, Leong-Poi H, Keating A, Marsden PA, Stewart DJ, and Gilbert RE
- Subjects
- Animals, Bone Marrow Cells pathology, Collagen chemistry, Creatinine blood, Culture Media, Conditioned pharmacology, Disease Models, Animal, Disease Progression, Glomerulonephritis pathology, Male, Rats, Rats, Inbred F344, Stromal Cells cytology, Transforming Growth Factor beta metabolism, Bone Marrow Cells cytology, Fibrosis pathology, Heart Injuries pathology, Kidney injuries, Kidney metabolism, Kidney Failure, Chronic pathology
- Abstract
Background: Most forms of chronic kidney disease are characterized by progressive renal and cardiac fibrosis leading to dysfunction. Preliminary evidence suggests that various bone marrow-derived cell populations have antifibrotic effects. In exploring the therapeutic potential of bone marrow derived cells in chronic cardio-renal disease, we examined the anti-fibrotic effects of bone marrow-derived culture modified cells (CMCs) and stromal cells (SCs)., Methodology/principal Findings: In vitro, CMC-conditioned medium, but not SC-conditioned medium, inhibited fibroblast collagen production and cell signalling in response to transforming growth factor-beta. The antifibrotic effects of CMCs and SCs were then evaluated in the 5/6 nephrectomy model of chronic cardio-renal disease. While intravascular infusion of 10(6) SCs had no effect, 10(6) CMCs reduced renal fibrosis compared to saline in the glomeruli (glomerulosclerosis index: 0.8+/-0.1 v 1.9+/-0.2 arbitrary units) and the tubulointersitium (% area type IV collagen: 1.2+/-0.3 v 8.4+/-2.0, p<0.05 for both). Similarly, 10(6) CMCs reduced cardiac fibrosis compared to saline (% area stained with picrosirius red: 3.2+/-0.3 v 5.1+/-0.4, p<0.05), whereas 10(6) SCs had no effect. Structural changes induced by CMC therapy were accompanied by improved function, as reflected by reductions in plasma creatinine (58+/-3 v 81+/-11 micromol/L), urinary protein excretion (9x/divided by 1 v 64x/divided by 1 mg/day), and diastolic cardiac stiffness (left ventricular end-diastolic pressure-volume relationship: 0.030+/-0.003 v 0.058+/-0.011 mm Hg/microL, p<0.05 for all). Despite substantial improvements in structure and function, only rare CMCs were present in the kidney and heart, whereas abundant CMCs were detected in the liver and spleen., Conclusions/significance: Together, these findings provide the first evidence suggesting that CMCs, but not SCs, exert a protective action in cardio-renal disease and that these effects may be mediated by the secretion of diffusible anti-fibrotic factor(s).
- Published
- 2010
- Full Text
- View/download PDF
24. Molecular imaging of endothelial progenitor cell engraftment using contrast-enhanced ultrasound and targeted microbubbles.
- Author
-
Kuliszewski MA, Fujii H, Liao C, Smith AH, Xie A, Lindner JR, and Leong-Poi H
- Subjects
- Animals, Collagen, Drug Combinations, Endothelial Cells cytology, Endothelial Cells metabolism, Graft Survival, Green Fluorescent Proteins genetics, H-2 Antigens genetics, Laminin, Luciferases, Firefly genetics, Neovascularization, Physiologic, Proteoglycans, Rats, Rats, Inbred F344, Transfection, Contrast Media, Endothelial Cells transplantation, Microbubbles, Stem Cell Transplantation, Ultrasonography methods
- Abstract
Aims: Imaging methods to track the fate of progenitor cells after their delivery would be useful in assessing the efficacy of cell-based therapies. We hypothesized that contrast-enhanced ultrasound (CEU) using microbubbles targeted to a genetically engineered cell-surface marker on endothelial progenitor cells (EPCs) would allow the targeted imaging of vascular engraftment., Methods and Results: Rodent bone marrow-derived EPCs were isolated, cultured, and transfected to express the marker protein, H-2Kk, on the cell surface. Non-transfected EPCs and EPCs transfected with either null plasmid or Firefly luciferase served as controls. Control microbubbles (MB(C)) and microbubbles targeted to H-2Kk expressed on EPCs (MB(H-2Kk)) were constructed. Binding of targeted microbubbles to EPCs was assessed in vitro using a parallel plate flow chamber system. CEU imaging of EPC-targeted microbubbles was assessed in vivo using subcutaneously implanted EPC-supplemented Matrigel plugs in rats. In flow chamber experiments, there was minimal attachment of microbubbles to plated control EPCs. Although numbers of adhered MB(C) were also low, there was greater and more diffuse attachment of MB(H-2Kk) to plated H-2Kk-transfected EPCs. Targeted CEU demonstrated marked contrast enhancement at the periphery of the H-2Kk-transfected EPC-supplemented Matrigel plug for MB(H-2Kk,) whereas contrast enhancement was low for MB(C). Contrast enhancement was also low for both microbubbles within control mock-transfected EPC plugs. The signal intensity within the H-2Kk-transfected EPC plug was significantly greater for MB(H-2Kk) when compared with MB(C)., Conclusion: Microbubbles targeted to a genetically engineered cell-surface marker on EPCs exhibit specific binding to EPCs in vitro. These targeted microbubbles bind to engrafted EPCs in vivo within Matrigel plugs and can be detected by their enhancement on CEU imaging.
- Published
- 2009
- Full Text
- View/download PDF
25. The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+-ATPase in the kidney.
- Author
-
Advani A, Kelly DJ, Cox AJ, White KE, Advani SL, Thai K, Connelly KA, Yuen D, Trogadis J, Herzenberg AM, Kuliszewski MA, Leong-Poi H, and Gilbert RE
- Subjects
- Analysis of Variance, Animals, Blotting, Western, Cells, Cultured, Disease Models, Animal, Female, Humans, Immunohistochemistry, In Situ Hybridization, Kidney Tubules, Collecting metabolism, Male, Membrane Proteins metabolism, Microscopy, Electron, Phosphorylation, Probability, Random Allocation, Rats, Rats, Sprague-Dawley, Reverse Transcriptase Polymerase Chain Reaction, Sensitivity and Specificity, Sodium-Bicarbonate Symporters metabolism, Prorenin Receptor, Biological Transport physiology, Kidney Tubules, Collecting cytology, Receptors, Cell Surface metabolism, Renin-Angiotensin System physiology, Vacuolar Proton-Translocating ATPases metabolism
- Abstract
The (pro)renin receptor ([P]RR) is a transmembrane protein that binds both renin and prorenin with high affinity, increasing the catalytic cleavage of angiotensinogen and signaling intracellularly through mitogen-activated protein kinase activation. Although initially reported as having no homology with any known membrane protein, other studies have suggested that the (P)RR is an accessory protein, named ATP6ap2, that associates with the vacuolar H(+)-ATPase, a key mediator of final urinary acidification. Using in situ hybridization, immunohistochemistry, and electron microscopy, together with serial sections stained with nephron segment-specific markers, we found that (P)RR mRNA and protein were predominantly expressed in collecting ducts and in the distal nephron. Within collecting ducts, the (P)RR was most abundant in microvilli at the apical surface of A-type intercalated cells. Dual-staining immunofluorescence demonstrated colocalization of the (P)RR with the B1/2 subunit of the vacuolar H(+)-ATPase, the ion exchanger that secretes H(+) ions into the urinary space and that associates with an accessory subunit homologous to the (P)RR. In collecting duct/distal tubule lineage Madin-Darby canine kidney cells, extracellular signal-regulated kinase 1/2 phosphorylation, induced by either renin or prorenin, was attenuated by the selective vacuolar H(+)-ATPase inhibitor bafilomycin. The predominant expression of the (P)RR at the apex of acid-secreting cells in the collecting duct, along with its colocalization and homology with an accessory protein of the vacuolar H(+)-ATPase, suggests that the (P)RR may function primarily in distal nephron H(+) transport, recently noted to be, at least in part, an angiotensin II-dependent phenomenon.
- Published
- 2009
- Full Text
- View/download PDF
26. Therapeutic arteriogenesis by ultrasound-mediated VEGF165 plasmid gene delivery to chronically ischemic skeletal muscle.
- Author
-
Leong-Poi H, Kuliszewski MA, Lekas M, Sibbald M, Teichert-Kuliszewska K, Klibanov AL, Stewart DJ, and Lindner JR
- Subjects
- Animals, Arterioles, DNA Packaging, DNA, Recombinant administration & dosage, DNA, Recombinant genetics, Endothelium, Vascular, Fluorocarbons administration & dosage, Genes, Reporter, Green Fluorescent Proteins analysis, Green Fluorescent Proteins genetics, Iliac Artery, Ligation, Liposomes, Microcirculation, Pharmaceutical Vehicles, Rats, Rats, Sprague-Dawley, Transcription, Genetic, Vascular Endothelial Growth Factor A biosynthesis, Collateral Circulation, Gene Transfer Techniques, Genetic Therapy methods, Hindlimb blood supply, Ischemia therapy, Microbubbles, Neovascularization, Physiologic, Sonication, Vascular Endothelial Growth Factor A genetics
- Abstract
Current methods of gene delivery for therapeutic angiogenesis are invasive, requiring either intraarterial or intramuscular administration. A noninvasive method of gene delivery has been developed using ultrasound-mediated destruction of intravenously administered DNA-bearing carrier microbubbles during their microcirculatory transit. Here we show that chronic ischemia could be markedly improved by ultrasound-mediated destruction of microbubbles bearing vascular endothelial growth factor-165 (VEGF(165)) plasmid DNA. Using a model of severe chronic hindlimb ischemia in rats, we demonstrated that ultrasound mediated VEGF(165)/green fluorescent protein (GFP) plasmid delivery resulted in a significant improvement in microvascular blood flow by contrast-enhanced ultrasound, and an increased vessel density by fluorescent microangiography, with minimal changes in control groups. The improvement in tissue perfusion was attributed predominantly to increases in noncapillary blood volume or arteriogenesis, with perfusion peaking at 14 days after delivery, followed by a partial regression of neovascularization at 6 weeks. Transfection was localized predominantly to the vascular endothelium of arterioles in treated ischemic muscle. RT-PCR confirmed the presence of VEGF(165)/GFP mRNA within treated ischemic muscle, being highest at day 3 postdelivery, and subsequently decreasing, becoming almost undetectable by 6 weeks. We found a modulation of endogenous growth factor expression in VEGF-treated ischemic muscle, consistent with a biologic effect of ultrasound mediated gene delivery. The results of our study demonstrate the utility of ultrasonic destruction of plasmid-bearing microbubbles to induce therapeutic arteriogenesis in the setting of severe chronic ischemia.
- Published
- 2007
- Full Text
- View/download PDF
27. Low-energy gamma-emitting stents inhibit intimal hyperplasia with minimal "edge effects" in a pig coronary artery model.
- Author
-
Kutryk MJ, Kuliszewski MA, Jaffe R, Tio FO, Janicki C, Sweet WL, Sparkes JD, and Strauss BH
- Subjects
- Animals, Disease Models, Animal, Dose-Response Relationship, Radiation, Gamma Rays, Hyperplasia radiotherapy, Palladium therapeutic use, Radioisotopes therapeutic use, Sus scrofa, Treatment Outcome, Brachytherapy, Coronary Restenosis prevention & control, Coronary Vessels pathology, Coronary Vessels radiation effects, Stents, Tunica Intima pathology, Tunica Intima radiation effects
- Abstract
Purpose: The objective of this study was to determine the effects of different doses of gamma-emitting radioactive stents on intimal hyperplasia in a porcine coronary stent model at 28 days., Methods: Sixty-four bare stents and those coated with palladium-103 [activities of 0 (control), 0.5, 1.0, 2.0, and 4.0 mCi] were implanted in the coronary arteries of 32 pigs. Stented segments were evaluated by histomorphometry at 28 days., Results: There was significantly more intima in the 0.5- and 1-mCi stents than in controls (4.27+/-0.52 and 4.71+/-1.13 vs. 1.71+/-0.61 mm(2); P<.0001). Neointimal formation in 2-mCi stents was similar to that in controls, while that in 4-mCi stents was reduced compared to that in controls (2.34+/-1.61 and 0.82+/-0.25 vs. 1.71+/-0.61 mm(2); P=NS and P<.05, respectively). Stent margin neointimal response was representative of that within the stent body, with nonsignficant modest increases in intimal area at adjacent nonstented segments in radioactive stent groups. There was a dose-dependent increase in inflammation scores. Radioactive stents had lower intimal smooth muscle and higher fibrin scores. There was an increase in adventitial fibrosis in 1- and 2-mCi stents versus controls (1.26+/-0.99, and 2.25+/-1.27 vs. 0.21+/-0.31; P<.001)., Conclusion: Dose-response inhibition of in-stent hyperplasia with minimal "edge effects" occurs with low-energy gamma-emitting stents. An increased inflammatory response at higher doses in palladium-103 stents indicates that later follow-up studies are necessary.
- Published
- 2007
- Full Text
- View/download PDF
28. Nitroglycerin attenuates human endothelial progenitor cell differentiation, function, and survival.
- Author
-
DiFabio JM, Thomas GR, Zucco L, Kuliszewski MA, Bennett BM, Kutryk MJ, and Parker JD
- Subjects
- Adolescent, Adult, Apoptosis drug effects, Apoptosis physiology, Cell Differentiation physiology, Cell Survival drug effects, Cell Survival physiology, Dose-Response Relationship, Drug, Endothelial Cells physiology, Humans, Male, Cell Differentiation drug effects, Cell Proliferation drug effects, Endothelial Cells cytology, Endothelial Cells drug effects, Nitroglycerin pharmacology
- Abstract
Endothelial progenitor cells (EPCs) participate in angiogenesis and the response to chronic ischemia. Risk factors and cardiovascular disease attenuate EPC number, function, and survival. Continuous therapy with nitroglycerin (glyceryl trinitrate; GTN) is associated with increased vascular oxidative stress, leading to nitrate tolerance and endothelial dysfunction. Thus, GTN therapy may also affect EPCs. The purpose of this study was to determine whether continuous exposure to GTN in vivo or during ex vivo expansion affects the circulating number and functional characteristics of human EPCs. To determine the effects of continuous in vivo GTN exposure, EPCs isolated from 28 healthy males before and after receiving 0.6 mg/h GTN (n=17) or no treatment (n=11) for 1 week were expanded for 6 days and compared. To determine the effects of continuous ex vivo GTN exposure, EPCs isolated before randomization were expanded for 6 days in medium supplemented with 100 nM, 300 nM, or 1 microM GTN. EPCs expanded without GTN served as controls (n=10). In vivo, GTN exposure significantly increased the percentage of circulating cells expressing the EPC marker CD34 and increased the susceptibility of expanded EPCs to apoptosis but had no impact on the phenotypic differentiation or migration of EPCs. Ex vivo, GTN exposure increased apoptosis while decreasing phenotypic differentiation, migration, and mitochondrial dehydrogenase activity of EPCs, compared with EPCs expanded in the absence of GTN. Taken together, these results suggest that continuous GTN therapy might impair EPC-mediated processes, an effect that could be detrimental in the setting of ischemic cardiovascular disease.
- Published
- 2006
- Full Text
- View/download PDF
29. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
- Author
-
Teichert-Kuliszewska K, Kutryk MJ, Kuliszewski MA, Karoubi G, Courtman DW, Zucco L, Granton J, and Stewart DJ
- Subjects
- Adult, Aged, Apoptosis, Bone Morphogenetic Protein 2, Bone Morphogenetic Protein Receptors, Type II analysis, Bone Morphogenetic Protein Receptors, Type II physiology, Bone Morphogenetic Proteins pharmacology, Cell Survival, Cells, Cultured, Endothelial Cells drug effects, Female, Humans, Hypertension, Pulmonary pathology, Male, Middle Aged, Stem Cells drug effects, Transforming Growth Factor beta pharmacology, Bone Morphogenetic Protein Receptors, Type II genetics, Endothelial Cells pathology, Hypertension, Pulmonary etiology, Mutation, Pulmonary Artery pathology, Signal Transduction physiology
- Abstract
Mutations in the bone morphogenetic protein (BMP) receptor-2 (BMPR2) have been found in patients with idiopathic pulmonary arterial hypertension (IPAH); however, the mechanistic link between loss of BMPR2 signaling and the development of pulmonary arterial hypertension is unclear. We hypothesized that, contrary to smooth muscle cells, this pathway promotes survival in pulmonary artery endothelial cells (ECs) and loss of BMPR2 signaling will predispose to EC apoptosis. ECs were treated with BMP-2 or BMP-7 (200 ng/mL) for 24 hours in regular or serum-free (SF) medium, with and without addition of tumor necrosis factor alpha, and apoptosis was assessed by flow cytometry (Annexin V), TUNEL, or caspase-3 activity. Treatment for 24 hours in SF medium increased apoptosis, and both BMP-2 and BMP-7 significantly reduced apoptosis in response to serum deprivation to levels not different from serum controls. Transfection with 5 microg of small interfering RNAs for BMPR2 produced specific gene silencing assessed by RT-PCR and Western blot analysis. BMPR2 gene silencing increased apoptosis almost 3-fold (P=0.0027), even in the presence of serum. Circulating endothelial progenitor cells (EPCs) isolated from normal subjects or patients with IPAH were differentiated in culture for 7 days and apoptosis was determined in the presence and absence of BMPs. BMP-2 reduced apoptosis induced by serum withdrawal in EPCs from normal subjects but not in EPCs isolated from patients with IPAH. These results support the hypothesis that loss-of-function mutations in BMPR2 could lead to increased pulmonary EC apoptosis, representing a possible initiating mechanism in the pathogenesis of pulmonary arterial hypertension.
- Published
- 2006
- Full Text
- View/download PDF
30. Reciprocal regulation of angiopoietin-1 and angiopoietin-2 following myocardial infarction in the rat.
- Author
-
Sandhu R, Teichert-Kuliszewska K, Nag S, Proteau G, Robb MJ, Campbell AI, Kuliszewski MA, Kutryk MJ, and Stewart DJ
- Subjects
- Angiopoietin-1 analysis, Angiopoietin-1 metabolism, Angiopoietin-2 analysis, Angiopoietin-2 metabolism, Animals, Blotting, Northern methods, Blotting, Western methods, Endothelium, Vascular chemistry, Endothelium, Vascular metabolism, Immunohistochemistry methods, Male, Neovascularization, Pathologic, Phosphorylation, Rats, Rats, Sprague-Dawley, Receptor, TIE-2 metabolism, Reverse Transcriptase Polymerase Chain Reaction, Angiopoietin-1 genetics, Angiopoietin-2 genetics, Gene Expression Regulation, Myocardial Infarction metabolism, Myocardium metabolism
- Abstract
Objective: This study sought to characterize changes in the angiopoietin system in a rat model of myocardial infarction (MI)., Background: Angiopoietin-1 (Ang-1) and angiopoietin-2 (Ang-2) bind to the endothelial-specific receptor tyrosine kinase, TIE-2. Ang-2 has been suggested to be an antagonist of TIE-2, possibly acting to release endothelial cells from the tonic stabilizing influence of Ang-1. However, on prolonged exposure, Ang-2 has been shown to acquire agonistic activity at TIE-2, raising the possibility that this isoform may play a direct role in neovascularization., Methods: Sprague-Dawley rats were subjected to left coronary ligation and myocardial tissues were harvested from the infarct and peri-infarct regions, or from non-infarcted myocardium. Changes in gene expression were determined by RT-PCR and confirmed by Northern analysis. Changes in protein expression were confirmed by Western analysis and immunocytochemistry, and TIE-2 activity was determined by immunoprecipitation with anti-TIE-2 and antiphosphotyrosine immunoblotting., Results: At 24 h, Ang-1 mRNA and protein expression within the infarct and peri-infarct regions were decreased compared to non-infarcted myocardium, whereas Ang-2 mRNA levels were markedly increased and TIE-2 expression was unchanged. Immunohistochemical staining revealed Ang-1 and TIE-2 immunoreactivity localized to vascular endothelium. In the infarct territory, Ang-2 immunostaining was localized primarily to invading leukocytes at 24 h. At 1 week, Ang-1 expression was partially restored, whereas Ang-2 expression remained elevated. At the time of peak elevation in Ang-2, Tie2 phosphorylation was found to be markedly increased, consistent with receptor activation., Conclusions: Thus, myocardial ischemia induced by left coronary artery ligation resulted in a sustained increase in Ang-2 expression and a reciprocal decrease in Ang-1, consistent with a predominant role for Ang-2 in the angiogenic response to MI.
- Published
- 2004
- Full Text
- View/download PDF
31. DNA integrity and transgene expression after passage through the NOGA needle catheter used for therapeutic myocardial angiogenesis.
- Author
-
Kuliszewski MA, Kutryk MJ, Sandhu R, Fitchett D, and Stewart DJ
- Abstract
BACKGROUND: The NOGA (Biosense Webster, Markham, ON, Canada) injection catheter is an innovative navigational device that provides an ideal platform for intra-myocardial injection material. However, injection through a long (1.91 m), narrow (27G) nitinol needle could result in deterioration in the integrity and functionality of DNA. METHODS: To test this possibility, DNA in plasmid form (pcDNA3.1) containing the Lac Z transgene (250 micro l) was passed through the NOGA needle using a hand-held 1 cc syringe at a gentle hand injection pressure (43 +/- 3 PSI, 3.0 +/- 0.2 kg/cm(2)) or at maximal manual pressure (90 +/- 6 PSI, 6.3 +/- 0.4 kg/cm(2)), either once or 20 times. This DNA, compared to DNA not passed through the NOGA needle (control), was then used to transfect primary cultures of rat skin fibroblasts (FB) from Fisher 344 rats and the cells were subsequently stained for beta galactosidase (betagal). RESULTS: Transfection efficiency was significantly reduced by passing the DNA through the needle at both 43 +/- 3 PSI (78 +/- 4% of control, n = 10, P < 0.05 versus control) and 90 +/- 6 PSI (66 +/- 4 % of control, n = 10, P < 0.01 versus control, P < 0.02 versus 43 +/- 3 PSI). Passage of the DNA through the NOGA needle 20 times resulted in a transfection efficiency of only 5 +/- 1% of control (n = 20, P < 0.1 x 10(-11) versus control). Capillary Electrophoresis revealed that the reduction in transfection efficiency was due to a conformational change in the DNA from predominantly supercoiled to nicked and linearized DNA. Transfection efficiency as compared with control decreased as the concentration of the DNA solution which was passed through the needle was increased from 0.3 micro g/ micro l to 2.4 micro g/ micro l. Recovery experiments confirmed that the reduction in transfection efficiency was not due to loss of DNA by binding to the NOGA needle. CONCLUSION: These results suggest that DNA is susceptible to shear forces when injected through the NOGA needle even at nominal clinical injection pressures, suggesting that careful and controlled injections will be required to achieve optimal gene integrity and expression.
- Published
- 2000
- Full Text
- View/download PDF
32. Cell-based gene transfer to the pulmonary vasculature: Endothelial nitric oxide synthase overexpression inhibits monocrotaline-induced pulmonary hypertension.
- Author
-
Campbell AI, Kuliszewski MA, and Stewart DJ
- Subjects
- Animals, Blood Pressure genetics, Cell Transplantation, Cells, Cultured, Flow Cytometry, Fluorescent Dyes, Gene Expression, Hypertension, Pulmonary chemically induced, Hypertension, Pulmonary enzymology, Lung metabolism, Monocrotaline, Muscle, Smooth, Vascular cytology, Muscle, Smooth, Vascular enzymology, Nitric Oxide Synthase Type III, Rats, Rats, Inbred F344, Rhodamines, Time Factors, Transfection, Ventricular Function, Right genetics, beta-Galactosidase biosynthesis, beta-Galactosidase genetics, Gene Transfer Techniques, Hypertension, Pulmonary therapy, Lung blood supply, Nitric Oxide Synthase biosynthesis, Nitric Oxide Synthase genetics
- Abstract
To circumvent the problems of in vivo transfection and avoid the use of viral vectors or proteins, we sought to establish whether smooth-muscle cells (SMCs) transfected ex vivo could be delivered via the systemic venous circulation into the pulmonary bed to achieve local transgene expression in the lung. Primary cultures of pulmonary artery SMCs from Fisher 344 rats were labeled with a fluorescent, membrane-impermeable dye chloromethyl trimethyl rhodamine or transfected with the beta-galactosidase (betaGal) reporter gene under the control of the cytomegalovirus (CMV) enhancer/promoter (pCMV-beta). Transfected or labeled SMCs (5 x 10(5) cells/animal) were delivered to syngeneic recipient rats by injection into the jugular vein; the animals were killed at intervals between 15 min and 2 wk; and the lungs, spleens, kidneys, and skeletal muscle were excised and examined. At 15 min after transplantation, injected cells were detected mainly in the lumen of small pulmonary arteries and arterioles, often in groups of three or more cells. After 24 h, labeled SMCs were found incorporated into the vascular wall of pulmonary arterioles, and transgene expression persisted in situ for 14 d with no evidence of immune response. Using simple geometric assumptions, it was calculated that approximately 57 +/- 5% of the labeled cells reintroduced into the venous circulation could be identified in the lungs after 15 min, 34 +/- 7% at 48 h, 16 +/- 3% at 1 wk, and 15 +/- 5% at 2 wk. Similar results were observed using cells transfected with the reporter gene betaGal. To determine whether this method of gene transfer could prove effective in inhibiting the development of pulmonary vascular disease, pulmonary artery SMCs were transfected with either the full-length coding sequence of endothelial nitric oxide synthase (NOS) under the control of the CMV enhancer/promoter or with the control vector (pcDNA3.1) and injected simultaneously with the pulmonary endothelial toxin monocrotaline. At 28 d after injection the right ventricular systolic pressure was significantly decreased from 50 +/- 4 mm Hg in animals injected with the null-transfected cells to 33 +/- 3 mm Hg in animals injected with the NOS-transfected cells (P < 0.01). These results suggest that a cell-based strategy of ex vivo transfection may provide an effective nonviral approach for the selective delivery of foreign transgenes to pulmonary microvessels in the treatment of pulmonary vascular disease.
- Published
- 1999
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.